Fig. 2: CT images showing changes from baseline in target and non-target lesions. | British Journal of Cancer

Fig. 2: CT images showing changes from baseline in target and non-target lesions.

From: A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours

Fig. 2

CT images showing changes from baseline in target lesion 1 at FU 16 (a) and 17 (b), target lesion 2 at FU 16 (c) and 17 (d) and non-target lesion 1 at FU 16 (e) and 17 (f) in the patient with uterine leiomyosarcoma and experiencing a prolonged PR in cohort B1. CT computed tomography, FU follow-up, PR partial response. NB. Baseline = 20 Dec 2017; FU 16 = 14 Jan 2020; FU 17 = 27 Apr 2020.

Back to article page